Insider Ledger
VRDN insider buying and SEC filings, explained
Viridian Therapeutics, Inc. · CIK 1590750
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- MIRAGEN THERAPEUTICS, INC.; SIGNAL GENETICS, INC.; SIGNAL GENETICS LLC
Insider activity in the last 12 months
Bought
$20.0M
Insiders who bought
1
Sold (not marked 10b5-1)
$419K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 19, 2026 | Sale | Jennifer Tousignant (Chief Legal Officer) sold 14,212 shares at $24.50 ($348K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| May 11, 2026 | Purchase (code P) | Fairmount Healthcare Fund II L.P. (Director and 10% owner) bought 1,176,470 shares indirectly (by entity) at $17.00 ($20.0M), reported as a purchase (code P). Holdings by entity up 30% to 5,090,928 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed May 13, 2026 |
| Dec 31, 2025 | Sale | Jennifer Tousignant (Chief Legal Officer) sold 2,272 shares at $31.16 ($71K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 2, 2026 |
13 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 4, 2026, 7:11 AM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow VRDN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.